+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Esophagoscopes and Gastroscopes Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 160 Pages
  • June 2023
  • Region: Global
  • Expert Market Research
  • ID: 5855080
The global esophagoscopes and gastroscopes market attained a value of USD 1.6 billion in 2022, driven by increasing prevalence of gastrointestinal disorders and growing adoption of minimally invasive procedures. The market is expected to grow at a CAGR of 5.7% during the forecast period of 2023-2031 to attain a value of USD 2.7 billion by 2031.

Esophagoscopes And Gastroscopes: Introduction

Esophagoscopes and gastroscopes are specialized medical instruments used for the examination and visualization of the oesophagus and stomach, respectively. They are flexible or rigid endoscopes that allow healthcare professionals to directly observe the internal structures of the oesophagus and stomach for diagnostic and therapeutic purposes.

The benefits of esophagoscopes and gastroscopes include:

  • Direct Visualization: Esophagoscopes and gastroscopes provide direct visualization of the esophagus and stomach, allowing for precise examination and identification of abnormalities. This helps in accurate diagnosis and targeted treatment planning
  • Minimally Invasive: The use of esophagoscopes and gastroscopes offers a minimally invasive approach compared to traditional surgical procedures. This reduces patient discomfort, decreases the risk of complications, and promotes faster recovery times
  • Tissue Sampling and Biopsy: These instruments facilitate the collection of tissue samples from the esophagus or stomach for pathological examination. Biopsies aid in determining the nature of abnormalities, guiding treatment decisions, and providing valuable information for disease staging or prognosis
  • Real-Time Imaging: Esophagoscopes and gastroscopes provide real-time imaging, allowing for immediate evaluation of the gastrointestinal tract. This helps in making immediate diagnostic and therapeutic decisions, reducing the need for additional procedures, or delaying treatment initiation
  • Customizable Interventions: With esophagoscopes and gastroscopes, therapeutic interventions can be tailored to the specific needs of each patient. This personalized approach enables healthcare professionals to address individual conditions and optimize treatment outcomes
It is important to note that the use of esophagoscopes and gastroscopes requires specialized training and expertise. These procedures are typically performed by gastroenterologists, surgeons, or other trained healthcare professionals in specialized endoscopy units or operating rooms, ensuring the safety and efficacy of the examinations and interventions.

Esophagoscopes And Gastroscopes Market Segmentations

The market can be categorised into esophagoscopes type, gastroscopes type, application, end user, and region.

Market Breakup by Esophagoscopes Type

  • Flexible Esophagoscopes
  • Rigid Esophagoscopes
  • Transnasal Esophagoscope

Market Breakup by Gastroscopes Type

  • Transnasal Gastroscopes
  • Dual-Channel Gastroscopes
  • Standard Gastroscopes
  • Therapeutic Gastroscopes
  • Others

Market Breakup by Application

  • Contraindications
  • Gastric Ulcer
  • Chronic Gastritis
  • Normal Mucosa
  • Others

Market Breakup by End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Diagnostic Centers
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Esophagoscopes And Gastroscopes Market Scenario

One of the key drivers of market growth is the increasing prevalence of gastrointestinal disorders and diseases. Conditions such as gastroesophageal reflux disease (GERD), esophagitis, gastric ulcers, and gastrointestinal cancers are becoming more prevalent globally. The growing incidence of these conditions necessitates the use of esophagoscopes and gastroscopes for accurate diagnosis, surveillance, and therapeutic interventions.

Moreover, advancements in endoscopic technologies and imaging modalities have significantly contributed to market expansion. The development of high-definition imaging systems, advanced optics, and improved illumination capabilities have enhanced the visualization and image quality during esophagoscopy and gastroscopy. These technological advancements enable healthcare professionals to detect abnormalities with greater precision and accuracy, leading to improved patient outcomes.

Furthermore, the increasing adoption of minimally invasive procedures and patient preference for less invasive diagnostic and therapeutic techniques have boosted the demand for esophagoscopes and gastroscopes. These instruments allow for direct visualization of the esophagus and stomach without the need for more invasive surgical interventions. Minimally invasive endoscopic procedures result in reduced patient discomfort, shorter hospital stays, and faster recovery times, which are significant advantages driving the market growth.

Additionally, the growing emphasis on early detection and preventive healthcare practices has led to an increased demand for regular screening and surveillance procedures. Esophagoscopes and gastroscopes play a crucial role in the early detection of gastrointestinal diseases and malignancies. Routine endoscopic examinations are recommended for individuals at high risk, such as those with a family history of gastrointestinal cancers or individuals with chronic conditions like GERD or Barrett's esophagus. This ongoing need for screening and surveillance drives the market growth of esophagoscopes and gastroscopes.

In conclusion, the esophagoscopes and gastroscopes market is expected to witness continued growth due to the increasing prevalence of gastrointestinal disorders, advancements in endoscopic technologies, the demand for minimally invasive procedures, and the emphasis on early detection and preventive healthcare practices. As the field of endoscopy continues to advance, further research and development, technological innovations, and training programs for healthcare professionals will shape the future of the esophagoscopes and gastroscopes market.

Key players in the global esophagoscopes and gastroscopes market

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the Esophagoscopes and Gastroscopes market are as follows:
  • FUJIFILM Corporation
  • B Braun Melsungen AG
  • Olympus Corporation
  • Smart Medical Systems
  • KARL STORZ
  • Medtronic Plc
  • HOYA GROUP
  • Aohua Endoscopy Co., Ltd
  • CONMED Corporation
  • Stryker Corporation
*The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Esophagoscopes and Gastroscopes Market Overview
3.1 Global Esophagoscopes and Gastroscopes Market Historical Value (2016-2022)
3.2 Global Esophagoscopes and Gastroscopes Market Forecast Value (2023-2031)
4 Global Esophagoscopes and Gastroscopes Market Dynamics
4.1 Market Drivers and Constraints
4.2 SWOT Analysis
4.3 Porter’s Five Forces Model
4.4 Key Demand Indicators
4.5 Key Price Indicators
4.6 Industry Events, Initiatives, and Trends
4.7 Value Chain Analysis
5 Global Esophagoscopes and Gastroscopes Market Segmentation
5.1 Global Esophagoscopes and Gastroscopes Market by Esophagoscopes Type
5.1.1 Market Overview
5.1.2 Flexible Esophagoscopes
5.1.3 Rigid Esophagoscopes
5.1.4 Transnasal Esophagoscope
5.2 Global Esophagoscopes and Gastroscopes Market by Gastroscopes Type
5.2.1 Market Overview
5.2.2 Transnasal Gastroscopes
5.2.3 Dual-Channel Gastroscopes
5.2.4 Standard Gastroscopes
5.2.5 Therapeutic Gastroscopes
5.2.6 Others
5.3 Global Esophagoscopes and Gastroscopes Market by Application
5.3.1 Market Overview
5.3.2 Contraindications
5.3.3 Gastric Ulcer
5.3.4 Chronic Gastritis
5.3.5 Normal Mucosa
5.3.6 Others
5.4 Global Esophagoscopes and Gastroscopes Market by End User
5.4.1 Market Overview
5.4.2 Hospitals
5.4.3 Ambulatory Surgical Centers
5.4.4 Specialty Clinics
5.4.5 Diagnostic Centers
5.4.6 Others
5.5 Global Esophagoscopes and Gastroscopes Market by Region
5.5.1 Market Overview
5.5.2 North America
5.5.3 Europe
5.5.4 Asia Pacific
5.5.5 Latin America
5.5.6 Middle East and Africa
6 North America Esophagoscopes and Gastroscopes Market
6.1 Market Share by Country
6.2 United States of America
6.3 Canada
7 Europe Esophagoscopes and Gastroscopes Market
7.1 Market Share by Country
7.2 United Kingdom
7.3 Germany
7.4 France
7.5 Italy
7.6 Others
8 Asia Pacific Esophagoscopes and Gastroscopes Market
8.1 Market Share by Country
8.2 China
8.3 Japan
8.4 India
8.5 ASEAN
8.6 Australia
8.7 Others
9 Latin America Esophagoscopes and Gastroscopes Market
9.1 Market Share by Country
9.2 Brazil
9.3 Argentina
9.4 Mexico
9.5 Others
10 Middle East and Africa Esophagoscopes and Gastroscopes Market
10.1 Market Share by Country
10.2 Saudi Arabia
10.3 United Arab Emirates
10.4 Nigeria
10.5 South Africa
10.6 Others
11 Regulatory Framework
11.1 Regulatory Overview
11.1.1 US FDA
11.1.2 EU EMA
11.1.3 INDIA CDSCO
11.1.4 JAPAN PMDA
11.1.5 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Clinical Trials Analysis
14.1 Analysis by Trial Registration Year
14.2 Analysis by Trial Status
14.3 Analysis by Trial Phase
14.4 Analysis by Therapeutic Area
14.5 Analysis by Geography
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 FUJIFILM Corporation
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 B Braun Melsungen AG
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Olympus Corporation.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Smart Medical Systems
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 KARL STORZ
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Medtronic Plc
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 HOYA GROUP
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Aohua Endoscopy Co., Ltd.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 CONMED Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Stryker Corporation
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
  • *Additional insights provided are customisable as per client requirements.

Companies Mentioned

  • FUJIFILM Corporation
  • B Braun Melsungen AG
  • Olympus Corporation.
  • Smart Medical Systems
  • KARL STORZ
  • Medtronic Plc
  • HOYA GROUP
  • Aohua Endoscopy Co., Ltd.
  • CONMED Corporation
  • Stryker Corporation

Methodology

Loading
LOADING...

Table Information